ECTRIMS Congress 2018 Coverage – Day 3

This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being discussed at the meeting.  The ECTRIMS Congress is the largest multiple sclerosis (MS) research conference in the world and, in 2018, the event was held in Berlin, Germany.

Our co-founder and chief science communicator, Brett Drummond, was in attendance and actively provided real-time insights via our Twitter account (@MStranslate).  On Day 3, he attended a wide range of presentations, that focussed on topics such as the use of siponimod to treat secondary progress multiple sclerosis, the use of biotin and lipoic acid to treat progressive multiple sclerosis and updates on the outcomes of both the BENEFIT and MS-SMART trials.  Shown below are a series of tweets he published throughout the day, which were fantastically received by both other conference attendees and members of the MS community around the world.

Revisit Brett’s insights from Day 1 here and Day 2 here.